Amby Laboratorie ApS: Financial statements 2023
CVR: 43447262
Source: annual report 2023, Danish Business Authority
16/08/2022 – 30/06/2023
Amby Laboratorie ApS (CVR 43447262) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 279,717 and a net result of DKK 11,661. Equity in the 2023 report amounted to DKK 47,241. The solvency ratio was 38.3%.
- Gross Profit
- DKK 279,717
- Profit/Loss
- DKK 11,661
- Equity
- DKK 47,241
- Total Assets
- DKK 123,385
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Amby Laboratorie ApS has published its interim report for the period August 16, 2022 to June 30, 2023.
About Amby Laboratorie ApS
Amby Laboratorie ApS was a Danish company of the type Anpartsselskab based in Tjele, founded in 2022. The company has been dissolved on 9 October 2026. The company was registered under the industry Anden teknisk rådgivning. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK 334,230 and a net result of DKK -29,518 compared with DKK 11,661 the year before. Equity in the 2024 report amounted to DKK 17,723.